Bone Biologics Corporation Financial Ratios — BBLGW Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-517	-2,302.39	-942.22	-482.52	-639.23	-11,838.26	-48.26	-19.57	-146.3	-108.23	-64.38
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7	5	9	8	9	11	12	- -	- -	- -	- -	- -
ST Debt	4	- -	1	- -	9	- -	12	- -	- -	- -	- -	- -
LT Debt	4	5	8	8	- -	11	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-2.43	-0.42	-0.43	-3.13	-3.22	-4.63	-14.21	- -	- -	- -	- -	- -
Net Debt/EBITDA	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
Total Debt/EBIT	-2.43	-0.42	-0.43	-3.13	-3.22	-4.63	-14.21	- -	- -	- -	- -	- -
Net Debt/EBIT	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EBITDA to Interest Expense	-2.15	-6.41	-6.43	-0.59	-2.27	-2.51	-0.83	-1.37	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-2.15	-6.41	-6.43	-0.59	-2.27	-2.51	-0.83	-1.37	- -	- -	- -	- -
EBIT to Interest Expense	-2.15	-6.41	-6.43	-0.59	-2.27	-2.51	-0.83	-1.37	- -	- -	- -	- -
Interest Expense	1	2	3	4	1	1	1	1	- -	- -	- -	- -
Common Equity/Total Assets	-314.38	-1,673.26	-7,429.99	-7,437.95	-6,110.14	-217,372.92	- -	-1,055.6	-847.06	-2,164.62	-2,201.83	-1,520.47
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-77.41	-24.44	-17.45	-16.15	- -	-20.33	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	95.39	328.59	1,078.68	1,034.32	- -	36,721.06	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-197.5	-89.47	-104.77	-98.02	-104.67	-95.39	-85.62	- -	- -	- -	- -	- -
Total Debt/Capital (%)	-155.11	-24.44	-20.22	-16.15	-16.49	-20.33	-20.52	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	191.15	328.59	1,249.82	1,034.32	864.79	36,721.06	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-125.54	-69.84	-97.36	-89.8	-93.56	-95.18	-85.62	-101.52	-126.75	-104.14	-95.45	-99.2
Net Debt/Capital (%)	-63	-18.1	-18.53	-14.6	-14.48	-20.27	-20.52	8.65	9.48	3.61	3.76	5.71
EBITDA	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
EBITDA-CapEx	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
Operating Income (Loss)	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3

Liquidity (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.69	0.52	0.41	0.72	0.1	0.04	- -	66.81	2.96	3.64	8.8	12.74
Current Ratio	0.98	0.72	0.47	0.83	0.11	0.05	- -	66.81	3.33	4.5	10.22	13.85
Quick Ratio	0.71	0.68	0.59	0.72	0.1	0.04	- -	66.81	3.19	4.04	8.8	12.77
CFO/Avg Current Liab	- -	-1.18	-4.02	-2.7	-0.77	-0.64	-0.06	-0.18	-2.69	-5.66	-6.82	-6.76
Common Equity/Total Assets	-314.38	-1,673.26	-7,429.99	-7,437.95	-6,110.14	-217,372.92	- -	-1,055.6	-847.06	-2,164.62	-2,201.83	-1,520.47
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-77.41	-24.44	-17.45	-16.15	- -	-20.33	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	95.39	328.59	1,078.68	1,034.32	- -	36,721.06	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-197.5	-89.47	-104.77	-98.02	-104.67	-95.39	-85.62	- -	- -	- -	- -	- -
Total Debt/Capital (%)	-155.11	-24.44	-20.22	-16.15	-16.49	-20.33	-20.52	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	191.15	328.59	1,249.82	1,034.32	864.79	36,721.06	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	-36.64	-49.06	-80.84	-36.23	-42.59	-27.32	-3.12	-1,229.71	-139.99	-1,149.37	-1,092.08	-642.91
CFO/CapEx	-231.55	-7,035.28	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-7.03	-49.52	-201.54	-115.28	-104.34	-3,327.93	- -	-14.14	-12.44	-37.7	-33.35	-22.02

Working Capital (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	3	1	1	1	1	- -	- -	7	8	3	3	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	5	9	8	9	11	12	- -	- -	- -	- -	- -
Enterprise Value	5	4	8	8	8	11	12	-7	-8	-3	-3	-5
Total Capital	-5	-21	-43	-51	-55	-56	-57	-70	-72	-81	-85	-88
Total Debt/Capital (%)	-155.11	-24.44	-20.22	-16.15	-16.49	-20.33	-20.52	- -	- -	- -	- -	- -
Total Debt / EV	1.57	1.28	1.08	1.09	1.12	1	1	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	6.89	- -	- -	20.49	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	6.89	- -	- -	20.49	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	5	4	8	8	8	11	12	-7	-8	-3	-3	-5
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
TTM Operating Income	-3	-12	-20	-3	-3	-2	-1	-1	-4	-9	-4	-3
TTM Cash Flow to Firm	-1	-2	-4	1	-3	-2	1	- -	-4	-10	-4	-3
TTM Free Cash Flow to Firm	-1	-2	-4	1	-3	-2	1	- -	-4	-10	-4	-3

Multiples (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	5	4	8	8	8	11	12	-7	-8	-3	-3	-5
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.88	4.71
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EV/EBITDA High	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EV/EBITDA Low	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EV/EBIT Average	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EV/EBIT High	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
EV/EBIT Low	-1.54	-0.33	-0.4	-2.87	-2.88	-4.62	-14.21	6.05	2.06	0.32	0.79	1.65
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.93	40.08	15.5
High Price	- -	- -	- -	- -	- -	- -	- -	- -	532.06	44.23	70.58	95.23
Enterprise Value Average	5	4	8	8	8	11	12	-7	-8	-3	-3	-5
Enterprise Value High	5	4	8	8	8	11	12	-7	-8	-3	-3	-5
Enterprise Value Low	5	4	8	8	8	11	12	-7	-8	-3	-3	-5

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Bone Biologics Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)